Department of Pharmaceutical Chemistry

Update from the Dean: How COVID-19 is affecting us and where to find updates

Fri Mar 27, 2020
Guglielmo
Elisabeth Fall

Dean B. Joseph Guglielmo, PharmD

Our COVID-19 response: How COVID-19 is affecting us and where to find updates.

Hunting for a cure for COVID-19: an insider’s story

Sat Mar 21, 2020
Krogan and Fabius

QBI’s director, Nevan Krogan, PhD, left, and Jacqueline Fabius, QBI's chief operating officer

The chief operating officer of the Quantitative Biosciences Institute (QBI) shares a view of the team's work on COVID-19.

2020 Mary Anne Koda-Kimble Seed Award for Innovation fuels vital research across the School

Fri Mar 20, 2020
Koda-Kimble
© majedphoto.com

Mary Anne Koda-Kimble, PharmD, former dean of the School of Pharmacy

The award funds the boldest, riskiest, and most blue-sky ideas.

School’s PharmD program rises to second place in national rankings

Tue Mar 17, 2020
Students in front of a pillar with a "UCSF" banner
Elisabeth Fall

The School of Pharmacy’s new ranking comes on the heels of last year’s update to the PharmD curriculum.

The new ranking comes on the heels of the School's recent update to its PharmD curriculum.

Thriving under stress: a QBI seminar with Kathleen Boris-Lawrie

Thu Feb 13, 2020
Boris-Lawrie
Nuclear proteins activate mTOR-resistant translation of select HIV-1 and host mRNAs

26th Annual Spring Research Seminar

Tue Feb 4, 2020
In the annual Spring Research Seminar, current scientific posters created by School of Pharmacy faculty, staff, fellows, residents, and students are presented. During the seminar, the creators of four posters are selected to receive the Gary Rifkind Award, each of which includes a prize of $1,000...

Sample medications and detailing visits add to costs, Guglielmo argues

Wed Jan 29, 2020
Guglielmo
Elisabeth Fall

UCSF School of Pharmacy Dean B. Joseph Guglielmo, PharmD

Free samples of medications and “detailing visits” are costly, B. Joseph Guglielmo argues in JAMA.

FDA, academia, and industry join forces to shepherd new therapies to patients

Thu Jan 23, 2020
Giacomini
Terrificshot

Kathy Giacomini, PhD, is co-director of UCSF-Stanford CERSI.

UCSF-Stanford CERSI brings together scientists, industry, and government regulators to get new therapies to patients sooner.

Modulation of innate immunity by arboviruses; beyond the STING: a QBI seminar with Ana Sesma

Wed Jan 22, 2020
Sesma
The QBI Seminar Series presents Ana Sesma, PhD, professor with tenure in the Department of Microbiology at Icahn School of Medicine at Mount Sinai. She is interested on the modulation of innate immunity by viruses of human health interests, such as dengue, influenza, human immunodeficiency virus...

Genomics characterization and surveillance of microbial threats in West Africa: a QBI seminar with Christian Happi

Wed Jan 22, 2020
Happi
The Infectious Disease and Human Health Seminar Series presents a seminar with Christian Happi. Happi is the director of the World Bank-funded African Center of Excellence for Genomics of Infectious Disease (ACEGID), professor of molecular biology and genomics, and the former dean of the College of...

Pages